SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
SocialPicks Community
Earnings Friday, November 13, 2009
SPPI
|
|
|
<> The short-term direction of SPPI's stock price will be more affected by SPPI's conference call than its actual quarterly results. The management of this company, in my opinion, is absolutely one of the worst when it comes to being transparent and straight with shareholders. Since the end of May 2009, the company has raised over $100 million with no clear business objectives only to dilute existing shareholder value. The stock is currently trading below the offering price of the lowest public offering. In addition, there are warrants outstanding on the offerings which could further dil<>...
|
Neutral on SPPI ...
SPPI
|
|
|
News of SPPI's drug delay is digesting. The stock should begin to increase again soon. A third of three catalysts is up for revue in the coming months and sales from the first should start to help the bottom line. All shareholders waist 2 in for the FDA outcome for catalyst 2 in the coming months.
|
Bullish on SPPI ...
SPPI
|
|
|
I am a recruiter for them. We are EXPANDING THEIR SALESFORCE FOR FIRST LINE ZEVALIN < AND COLON CANCER SALES OF FUSILEV.
|
RECENT NEWS
SPPI
|
|
|
spectrum Pharma tgt raised to $10 at Rodman & Renshaw following FDA approval for the expanded label of Zevalin Rodman & Renshaw raise their SPPI tgt to $10 from $8 following the FDA approval for an expanded label of Zevalin, which treats the previously untreated follicular non-Hodgkin's Lymphoma. With the label expansion, the treatable population expands from 6,000 to potentially 43,000 patients annually, in the firm's opinion.
|
Recent News
SPPI
|
|
|
Downgrade from Buy to Hold -Morgan.
|
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on SPPI |
Visit streetinsider.com
Be the first to start a discussion and earn 2 points.
More Resources
|
About Spectrum Pharmaceuticals Inc.
- Answers.com
